ArticleRand health quarterly2026
The Effect of the Massachusetts Health Care Cost Growth Benchmark on Hospital Revenues and Other Spending Outcomes: Associations with Hospital Revenue, Hospital Prices, and Insurance Premiums.
Article in Rand health quarterly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the authors evaluate the effects of Massachusetts's health care cost growth benchmark-established in 2012 to constrain health care spending-on hospital revenues, health care prices, and health insurance premiums. The cost growth benchmark, enforced by the Massachusetts Health Policy Commission, sets annual spending growth targets and includes accountability measures for providers and payers. Although the cost growth benchmark was exceeded in most years since 2013, the policy may have slowed spending growth compared with what would have occurred otherwise. The study uses four statistical approaches to estimate the benchmark's effects, comparing Massachusetts hospitals and counties with various groups of hospitals and counties in other states and employing pre- and post-policy data. Results were mixed and method-dependent: Some approaches suggested that the cost growth benchmark reduced inpatient and outpatient hospital revenue and prices, while the authors found no significant effects in other approaches. There was no evidence that the benchmark affected health insurance premiums. The analysis was limited by confounding factors, especially the near-simultaneous implementation of the Affordable Care Act, and by differences among Massachusetts and comparison states. The authors caution that findings are exploratory and not causal. Overall, the evidence that the Massachusetts health care cost growth benchmark reduced hospital revenue and prices was weak and inconsistent. The authors suggest that stronger enforcement or complementary policies may be needed to more effectively control health care spending growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.